These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37608620)

  • 21. Hippocampal and Amygdalar Morphological Abnormalities in Alzheimer's Disease Based on Three Chinese MRI Datasets.
    Wei Y; Huang N; Liu Y; Zhang X; Wang S; Tang X
    Curr Alzheimer Res; 2020; 17(13):1221-1231. PubMed ID: 33602087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies.
    Mak E; Gabel S; Su L; Williams GB; Arnold R; Passamonti L; Vazquez Rodríguez P; Surendranathan A; Bevan-Jones WR; Rowe JB; O'Brien JT
    Int Psychogeriatr; 2017 Apr; 29(4):545-555. PubMed ID: 28088928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
    Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
    Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Right hippocampus atrophy is independently associated with Alzheimer's disease with psychosis.
    Lee K; Lee YM; Park JM; Lee BD; Moon E; Jeong HJ; Kim SY; Chung YI; Kim JH
    Psychogeriatrics; 2019 Mar; 19(2):105-110. PubMed ID: 30430708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetry.
    Sankar T; Park MTM; Jawa T; Patel R; Bhagwat N; Voineskos AN; Lozano AM; Chakravarty MM;
    Hum Brain Mapp; 2017 Jun; 38(6):2875-2896. PubMed ID: 28295799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series.
    Prestia A; Caroli A; Herholz K; Reiman E; Chen K; Jagust WJ; Frisoni GB; ;
    Alzheimers Dement; 2013 Nov; 9(6):677-86. PubMed ID: 23375562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The EADC-ADNI harmonized protocol for hippocampal segmentation: A validation study.
    Zandifar A; Fonov VS; Pruessner JC; Collins DL;
    Neuroimage; 2018 Nov; 181():142-148. PubMed ID: 29966720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating Alzheimer's disease progression using rate of regional hippocampal atrophy.
    Frankó E; Joly O;
    PLoS One; 2013; 8(8):e71354. PubMed ID: 23951142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
    Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
    Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease diagnosis based on the Hippocampal Unified Multi-Atlas Network (HUMAN) algorithm.
    Amoroso N; Rocca M; Bellotti R; Fanizzi A; Monaco A; Tangaro S;
    Biomed Eng Online; 2018 Jan; 17(1):6. PubMed ID: 29357893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI.
    Wolz R; Heckemann RA; Aljabar P; Hajnal JV; Hammers A; Lötjönen J; Rueckert D;
    Neuroimage; 2010 Aug; 52(1):109-18. PubMed ID: 20382238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causal structural covariance network revealing atrophy progression in Alzheimer's disease continuum.
    Qing Z; Chen F; Lu J; Lv P; Li W; Liang X; Wang M; Wang Z; Zhang X; Zhang B;
    Hum Brain Mapp; 2021 Aug; 42(12):3950-3962. PubMed ID: 33978292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.
    Varon D; Barker W; Loewenstein D; Greig M; Bohorquez A; Santos I; Shen Q; Harper M; Vallejo-Luces T; Duara R;
    Int J Geriatr Psychiatry; 2015 Feb; 30(2):192-200. PubMed ID: 24816477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease.
    Cover KS; van Schijndel RA; Versteeg A; Leung KK; Mulder ER; Jong RA; Visser PJ; Redolfi A; Revillard J; Grenier B; Manset D; Damangir S; Bosco P; Vrenken H; van Dijk BW; Frisoni GB; Barkhof F;
    Psychiatry Res Neuroimaging; 2016 Jun; 252():26-35. PubMed ID: 27179313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
    Allison SL; Koscik RL; Cary RP; Jonaitis EM; Rowley HA; Chin NA; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Bendlin BB; Johnson SC
    Neuroimage Clin; 2019; 23():101895. PubMed ID: 31252287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
    Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Hua X; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
    Hum Brain Mapp; 2009 Sep; 30(9):2766-88. PubMed ID: 19172649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
    Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
    Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
    Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
    Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.